These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 16528251

  • 1. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney.
    Sachetelli S, Liu Q, Zhang SL, Liu F, Hsieh TJ, Brezniceanu ML, Guo DF, Filep JG, Ingelfinger JR, Sigmund CD, Hamet P, Chan JS.
    Kidney Int; 2006 Mar; 69(6):1016-23. PubMed ID: 16528251
    [Abstract] [Full Text] [Related]

  • 2. Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.
    Lo CS, Liu F, Shi Y, Maachi H, Chenier I, Godin N, Filep JG, Ingelfinger JR, Zhang SL, Chan JS.
    Am J Physiol Renal Physiol; 2012 Apr 01; 302(7):F840-52. PubMed ID: 22205225
    [Abstract] [Full Text] [Related]

  • 3. Renin angiotensin system blockade ameliorates lead nephropathy.
    Ng HY, Tain YL, Lee YT, Hsu CY, Chiou TT, Huang PC, Lee CT.
    Biochem Biophys Res Commun; 2013 Aug 23; 438(2):359-63. PubMed ID: 23896603
    [Abstract] [Full Text] [Related]

  • 4. Effect of renin-angiotensin system blockade on the expression of the angiotensinogen gene and induction of hypertrophy in rat kidney proximal tubular cells.
    Zhang SL, To C, Chen X, Filep JG, Tang SS, Ingelfinger JR, Carrière S, Chan JS.
    Exp Nephrol; 2001 Aug 23; 9(2):109-17. PubMed ID: 11150859
    [Abstract] [Full Text] [Related]

  • 5. Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells.
    Hsieh TJ, Fustier P, Wei CC, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Fantus IG, Hamet P, Chan JS.
    J Endocrinol; 2004 Dec 23; 183(3):535-50. PubMed ID: 15590980
    [Abstract] [Full Text] [Related]

  • 6. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.
    Vaněčková I, Kujal P, Husková Z, Vaňourková Z, Vernerová Z, Certíková Chábová V, Skaroupková P, Kramer HJ, Tesař V, Červenka L.
    Kidney Blood Press Res; 2012 Dec 23; 35(5):382-92. PubMed ID: 22487948
    [Abstract] [Full Text] [Related]

  • 7. Ganglionic action of angiotensin contributes to sympathetic activity in renin-angiotensinogen transgenic mice.
    Ma X, Sigmund CD, Hingtgen SD, Tian X, Davisson RL, Abboud FM, Chapleau MW.
    Hypertension; 2004 Feb 23; 43(2):312-6. PubMed ID: 14699002
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of angiotensinogen increases tubular apoptosis in diabetes.
    Liu F, Brezniceanu ML, Wei CC, Chénier I, Sachetelli S, Zhang SL, Filep JG, Ingelfinger JR, Chan JS.
    J Am Soc Nephrol; 2008 Feb 23; 19(2):269-80. PubMed ID: 18057217
    [Abstract] [Full Text] [Related]

  • 9. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
    Perico N, Zoja C, Corna D, Rottoli D, Gaspari F, Haskell L, Remuzzi G.
    Kidney Int; 2009 Nov 23; 76(9):960-7. PubMed ID: 19625993
    [Abstract] [Full Text] [Related]

  • 10. Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice.
    Davisson RL, Ding Y, Stec DE, Catterall JF, Sigmund CD.
    Physiol Genomics; 1999 Jul 15; 1(1):3-9. PubMed ID: 11015555
    [Abstract] [Full Text] [Related]

  • 11. A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes.
    Major TC, Olszewski B, Rosebury W, Okerberg C, Carlson T, Ostroski R, Schroeder R, Kowala MC, Leadley R.
    Cardiovasc Drugs Ther; 2008 Dec 15; 22(6):469-78. PubMed ID: 18679781
    [Abstract] [Full Text] [Related]

  • 12. The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease.
    Goto M, Hoxha N, Osman R, Dell KM.
    Pediatr Nephrol; 2010 Dec 15; 25(12):2449-57. PubMed ID: 20798958
    [Abstract] [Full Text] [Related]

  • 13. Renin-angiotensin system blockade alone or combined with ETA receptor blockade: effects on the course of chronic kidney disease in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.
    Sedláková L, Čertíková Chábová V, Doleželová Š, Škaroupková P, Kopkan L, Husková Z, Červenková L, Kikerlová S, Vaněčková I, Sadowski J, Kompanowska-Jezierska E, Kujal P, Kramer HJ, Červenka L.
    Clin Exp Hypertens; 2017 Dec 15; 39(2):183-195. PubMed ID: 28287881
    [Abstract] [Full Text] [Related]

  • 14. Four-week inhibition of the renin-angiotensin system in spontaneously hypertensive rats results in persistently lower blood pressure with reduced kidney renin and changes in expression of relevant gene networks.
    Byars SG, Prestes PR, Suphapimol V, Takeuchi F, De Vries N, Maier MC, Melo M, Balding D, Samani N, Allen AM, Kato N, Wilkinson-Berka JL, Charchar F, Harrap SB.
    Cardiovasc Res; 2024 May 29; 120(7):769-781. PubMed ID: 38501595
    [Abstract] [Full Text] [Related]

  • 15. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
    Mitchell KD, Bagatell SJ, Miller CS, Mouton CR, Seth DM, Mullins JJ.
    J Renin Angiotensin Aldosterone Syst; 2006 Jun 29; 7(2):74-86. PubMed ID: 17083061
    [Abstract] [Full Text] [Related]

  • 16. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
    Naelten G, Liu KL, Chapuis B, Lo M.
    Am J Hypertens; 2005 May 29; 18(5 Pt 1):699-706. PubMed ID: 15882554
    [Abstract] [Full Text] [Related]

  • 17. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
    Nagata S, Kato J, Kuwasako K, Asami M, Kitamura K.
    Hypertens Res; 2012 Feb 29; 35(2):234-8. PubMed ID: 21993212
    [Abstract] [Full Text] [Related]

  • 18. Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats.
    Ohashi N, Yamamoto T, Huang Y, Misaki T, Fukasawa H, Suzuki H, Togawa A, Suzuki S, Fujigaki Y, Nakagawa T, Nakamura Y, Suzuki F, Kitagawa M, Hishida A.
    Am J Physiol Renal Physiol; 2008 Nov 29; 295(5):F1512-8. PubMed ID: 18784264
    [Abstract] [Full Text] [Related]

  • 19. Differential evolution of blood pressure and renal lesions after RAS blockade in Lyon hypertensive rats.
    Bertram D, Blanc-Brunat N, Sassard J, Lo M.
    Am J Physiol Regul Integr Comp Physiol; 2002 Nov 29; 283(5):R1041-5. PubMed ID: 12376396
    [Abstract] [Full Text] [Related]

  • 20. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P, Chábová VČ, Vernerová Z, Walkowska A, Kompanowska-Jezierska E, Sadowski J, Vaňourková Z, Husková Z, Opočenský M, Skaroupková P, Schejbalová S, Kramer HJ, Rakušan D, Malý J, Netuka I, Vaněčková I, Kopkan L, Cervenka L.
    Clin Exp Pharmacol Physiol; 2010 Dec 29; 37(12):1159-69. PubMed ID: 20880190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.